The goal of the study was to determine if there is a CFTR dose effect with Cftr +/- mice having elevated membrane cholesterol intermediated between wt and CF models, or if there was actually a loss of membrane cholesterol as seen with acute CFTR inhibition. The gene discussed is CFTR; the disease is cystic fibrosis.